Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinhong Decoction plus high-position colon sequential purification for sepsis
ChiCTR2100049461Phase 4Recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Jan 2020
- Countries
- 1
01
Overview
Phase 4, randomised trial of jinhong decoction in sepsis (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: 28-day all-cause mortality. Started Jan 2020; status: recruiting.
02
Drugs
jinhong decoction
03
Conditions
sepsis
Beyond the preview
Go deeper on ChiCTR2100049461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049461.